Enter your terms above and click the 'Search' button.

Showing articles 0 to 4 of 4 Filter Applied: efficacy (Click to remove) A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis NEJM 392:2309-2320, Nowak,R.J.,et al, 2025 Myasthenia Gravis - Redemption for B-Cell Depletion NEJM 392:2382-2384, Wolfe,G.I. & Shelly,S., 2025 Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis NEJM 376:221-234,280, Hauser, S.L.,et al, 2017 Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis NEJM 376:209-220,280, Montalban, X.,et al, 2017 Showing articles 0 to 4 of 4